This study presents the results of a hospital survey on Lyme disease in chi
ldren living in upper Normandy, a region that is quite densely wooded (with
18% forest areas and woods). The aim of this survey was to assess the prev
alence of this disease in children from the Seine-Maritime and L'Eure, hosp
italized in pediatric wards in the Seine-Maritime department, which include
s Rouen, Dieppe, Fecamp, Elbeuf, and Le Havre. Fifteen cases of Lyme diseas
e were diagnosed between September 1988 and June 1997. The children (6 girl
s and 9 boys) were aged between 5 and 14 years old Only 7 subjects showed p
rimary symptoms, while secondary symptoms were observed in 12 children. In
the study population, a high prevalence (11 out of the 15 children) of neur
ological disorders was found. The following secondary symptoms were noted:
5 cases of erythema migrans, 2 cases of non-malignant cutaneous lymphocytom
a, and 4 cases which in fact had previously displayed primary clinical sign
s (3 subjects with erythema migrans and 1 subject with non-malignant cutane
ous lymphocytoma); 7 cases of uni- or bilateral facial paralysis, the most
frequent neurological manifestation with or without lymphocytic meningitis;
1 case of central vestibular syndrome with a hyperalgesic meningoradicular
reaction in the vicinity of the tick bite; 1 case of peripheral radicular
involvement and intense pain in the left lower limb; 4 cases of ocular diso
rders (3 diplopias, 1 bilateral conjunctivitis complicated by kerato-uveiti
s, 1 bilateral complete cecitis). Only 10 child had rheumatological symptom
s, ie Lyme arthritis of the right knee. Treatment consisted of amoxicillin
(10 children) administered at a dosage of 50 to 100 mg/kg/d over a period r
anging from 10 days to 1 month, or ceftriaxone (7 children) at a dosage of
50 to 100 mg/kg/d administered intravenously over a period ranging from 8 d
ays to 3 weeks. Two of the children received combined antibiotic therapy an
d 5 subjects had adjunct corticotherapy The outcome was favorable in all ca
ses. (C) 2000 Editions scientifiques et medicales Elsevier SAS.